Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer
Black, A. R., Black, J. D., & Azizkhan‐Clifford, J. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1111 · Cited by 1,049
Wei, D., Le, X., Zheng, L., Wang, L., Frey, J. A., Gao, A. C., Peng, Z., Huang, S., Xiong, H. Q., Abbruzzese, J. L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206122 · Cited by 558
Sp1 and the ‘hallmarks of cancer’
Beishline, K., & Azizkhan‐Clifford, J. (2015) · The FEBS Journal · doi:10.1111/febs.13148 · Cited by 524
Sp transcription factor family and its role in cancer
Safe, S., & Abdelrahim, M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.006 · Cited by 500
Qin, Y., & Hurley, L. H. (2008) · Biochimie · doi:10.1016/j.biochi.2008.02.020 · Cited by 450
PAGES, G., & POUYSSEGUR, J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.032 · Cited by 443
i-Motif DNA: Structure, stability and targeting with ligands
Day, H. A., Pavlou, P., & Waller, Z. A. E. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.047 · Cited by 383
Fahmy, R. G., Dass, C. R., Sun, L.-Q., Chesterman, C. N., & Khachigian, L. M. (2003) · Nature Medicine · doi:10.1038/nm905 · Cited by 361
Nowak, D. G., Woolard, J., Amin, E. M., Konopatskaya, O., Saleem, M. A., Churchill, A. J., Ladomery, M. R., Harper, S. J., & Bates, D. O. (2008) · Journal of Cell Science · doi:10.1242/jcs.016410 · Cited by 339
von Marschall, Z., Scholz, A., Cramer, T., Schafer, G., Schirner, M., Oberg, K., Wiedenmann, B., Hocker, M., & Rosewicz, S. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.437 · Cited by 328
Sen, C. K., Khanna, S., Babior, B. M., Hunt, T. K., Ellison, E. C., & Roy, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203391200 · Cited by 324
STAT3: A critical transcription activator in angiogenesis
Chen, Z., & Han, Z. C. (2008) · Medicinal Research Reviews · doi:10.1002/med.20101 · Cited by 305
Chintharlapalli, S., Papineni, S., Ramaiah, S. K., & Safe, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3735 · Cited by 297
Xu, L., Fukumura, D., & Jain, R. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108347200 · Cited by 281
Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy
Asamitsu, S., Obata, S., Yu, Z., Bando, T., & Sugiyama, H. (2019) · Molecules · doi:10.3390/molecules24030429 · Cited by 275
EWS–ETS oncoproteins: The linchpins of Ewing tumors
Janknecht, R. (2005) · Gene · doi:10.1016/j.gene.2005.08.007 · Cited by 173
Tissue Repair with a Therapeutic Transcription Factor
Bryant, M., Drew, G. M., Houston, P., Hissey, P., Campbell, C. J., & Braddock, M. (2000) · Human Gene Therapy · doi:10.1089/104303400750001444 · Cited by 74
Cascio, S., Ferla, R., D'Andrea, A., Gerbino, A., Bazan, V., Surmacz, E., & Russo, A. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21843 · Cited by 53
“The VEGF and leptin gene promoters contain several regulatory motif as ERE, CRE, SP-1, AP-2, HRE, and SRE (STAT3-responsive element) (Finkenzeller et al., 1997; Mason et al., 1998; Brenneisen et al., 2003).”
Background
Metadata
- Authors
- Finkenzeller, G., Sparacio, A., Technau, A., Marmé, D., & Siemeister, G.
- Venue
- Oncogene
- Published
- 1997-08-07
- Volume
- 15
- Issue
- 6
- Pages
- 669-676
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2041140715
- Cited by
- 201
- References
- 0
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.